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Abstract Objectives: To assess clinical presentation, treatment, and outcome of children with Ebstein’s
anomaly. Background: Data on long-term outcome of children with Ebstein’s anomaly are scarce.
Methods: Retrospective analysis of all children with Ebstein’s anomaly treated between February, 1979 and
January, 2009 in a single tertiary institution. Primary outcomes included patient survival and need for
intervention, either cardiac surgery or catheter intervention. Results: A total of 42 patients were diagnosed
with Ebstein’s anomaly at a median age of 5 days ranging from 1 day to 11.7 years. Symptoms included
cyanosis, heart murmur, and/or dyspnoea. Associated cardiac anomalies occurred in 90% of the patients.
Average follow-up was 9.5 plus or minus 7.0 years. The overall mortality rate was 14%. Of the six patients,
three died postnatally before treatment. Cardiac surgery and/or catheter-guided interventions were required in
33 patients (79%). Cardiac surgery was performed in 21 (50%) patients at a median age of 9.1 years (range
0.1–16.5 years), including biventricular repair in 13 (62%), one-and-a-half chamber repair in seven (33%),
and a staged single-ventricle repair in one. Peri-operative mortality was 4%. Catheter-guided interventions
consisted of device closure of an atrial septal defect in three cases and radiofrequency ablation of accessory
pathways in nine patients. The estimated 10-year survival was 85.3 plus or minus 5.6%. Conclusion: In
children, Ebstein’s anomaly is usually diagnosed in the first year of age. Even though children with Ebstein’s
anomaly often require an intervention, their peri-operative mortality is low and long-term survival is good.
Symptomatic newborns requiring an intervention may have a worse outcome.
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E
BSTEIN’S ANOMALY IS A RARE CONGENITAL HEART
defect occurring in 1–5 of 200,000 live births,
accounting for less than 1% of all congenital
heart defects.1 It encompasses a wide anatomic
spectrum of abnormalities of the tricuspid valve and
of the right ventricle including atrialisation of parts of
the right ventricle due to apical displacement of the
septal and posterior tricuspid valve leaflets. Additional
cardiac anomalies are common and include atrial
septal defect in up to 90%, accessory pathways
leading to ventricular pre-excitation in approxi-
mately 15% of cases,2 and more rarely noncompac-
tion of the left ventricular myocardium.3 Ebstein’s
anomaly may manifest at any age, ranging from the
prenatal stage to older age.4 Clinical presentation is
usually age dependent:5 neonates may present with
cyanosis, congestive heart failure, and marked cardi-
omegaly; older children may have signs of progressive
right ventricular failure; adolescents and adults often
present with palpitations due to arrhythmias or mild
symptoms such as exertional dyspnoea.1
The techniques of tricuspid valve reconstruction
have evolved during the last decades, and a biventricular
repair with a competent tricuspid valve can usually
be achieved with good results.6–8
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Ebstein’s anomaly is being increasingly diagnosed
early in life. Previous studies identified cyanosis and
need for early intervention as risk factors for poor
outcome in neonates and young children.9–13
Thus, management of symptomatic children with
Ebstein’s anomaly remains challenging and addi-
tional interventions such as systemic-to-pulmonary
artery shunts, cavopulmonary shunts, and radio-
frequency ablations of supraventricular arrhythmias
due to pre-excitation and/or transcatheter device
closure of interatrial shunts may be necessary before
or after tricuspid valve surgery.14,15 In the most severe
cases, the Fontan procedure with right ventricular
exclusion may be the surgical treatment of choice.12,16
We sought to assess clinical presentation, treat-
ment strategies, and outcome in a cohort of neonates
and children with Ebstein’s anomaly.
Methods
Medical and surgical reports, echocardiographic find-
ings, and 12-lead electrocardiograms of all consecutive
liveborns diagnosed with Ebstein’s anomaly at our
institution between 1979 and 2009 were retrospectively
reviewed. Particular focus was given to symptoms,
treatment strategies including surgical and catheter-
guided interventions, as well as to follow-up. Follow-up
was performed either by arranging a clinical visit to our
centre (33 patients) or by contacting the treating
physician (three patients).
Primary end-points included patient survival and
need for intervention, either cardiac surgery or catheter-
guided interventions including radiofrequency ablation
and/or interventional device closure of secundum atrial
septal defect.
The study was approved by the local ethics
committee.
Surgical strategy and operative technique
Indications for surgical intervention in the neonatal
period included ventilator dependency, prostaglandin-
dependent circulation, and/or severe cardiac failure. A
symptomatic newborn was allowed time for transition
from the foetal circulation, particularly for regression
of neonatal pulmonary hypertension. Usually, a
systemic-to-pulmonary artery shunt was chosen as
the primary modality to relieve cyanosis.
Intracardiac corrective surgery was performed in
older children presenting with one or a combination of
the following: congestive heart failure, New York
Heart Association functional class III, cyanosis with
saturations below 90%, and arrhythmias refractory to
medical treatment. Although difficult to determine
in retrospect, the most common indication was
presence of right-sided heart congestion resulting
from moderate or severe tricuspid regurgitation.
Biventricular correction involving tricuspid valve
repair with plication of the atrialised right ventricle
free wall and a pulmonary commissurotomy or either
transannular monocusp patch or right ventricle to
pulmonary artery valved conduit was the preferred
technique. Tricuspid valve repair involved detachment
of the displaced septal, posterior, and even anterior
leaflet from their abnormal attachment to the free wall
of the right ventricle, re-attachment of the leaflets to
the virtual neo-annulus, and then ultimately reducing
the neo-annulus with an annuloplasty. The valve
was then bestowed upon with a parachute subvalvar
apparatus, by creating multiple artificial neo-chordae
(Goretexs suture, W.L. Gore & Associate, Inc.,
Flagstaff, Arizona, United States of America). When
tricuspid valve competence could not be achieved, the
valve was replaced with a biological valve. We have
used an age-adjusted Contegras (Contegra, Medtronic,
Inc., Minneapolis, Minnesota, United States of
America) xenograft valve indigenously housed in a
Goretexs tube to replace the tricuspid valve in one
patient. In cases of significant displacement of the
tricuspid valve leaflets, with borderline functional
right ventricle, a bidirectional Glenn anastomosis was
performed to create a one-and-a-half ventricle repair.
Most severe forms of Ebstein’s anomaly with severely
impaired right ventricular volume and function
underwent a staged univentricular repair. The surgical
technique chosen was determined by the severity of
tricuspid valve dysplasia and of impairment of the
right ventricular size and function, as well as presence
of functional pulmonary atresia.
Catheter intervention
Indication for transcatheter device closure of a
secundum atrial septal defect was presence of a
haemodynamic relevant shunt if oxygen saturation
was normal at rest and during exercise testing, or
presence of cyanosis or desaturation below 90%, at
rest or during exercise.
Catheter ablation
Invasive electrophysiology examination with radio-
frequency ablation was performed in all patients with
obvious accessory pathway on electrocardiogram and/or
clinical symptomatic tachyarrhythmias. If radio-
frequency ablation was inefficient in treating recurrent
tachyarrhythmias, surgical cryoablation was planned
during surgical repair.
Statistical methods
Continuous data are expressed as median and range,
nominal data as frequencies. Actuarial survival
was analysed using the Kaplan–Meier method.
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Peri-operative mortality was defined as mortality
within 30 days after operation.
Results
General findings
A total of 42 patients with Ebstein’s anomaly, 52%
boys, were included in the study. Diagnosis was
made at a median age of 5 days – range from 1 day
to 11.7 years, and in 86% of the patients during the
first year of life (Fig 1). In 9 cases, Ebstein’s anomaly
was diagnosed prenatally: four of them died, two
received tricuspid valve repair at a later age, one had
a one-and-a-half ventricle repair, and one patient
never underwent any intervention. A syndromal
disorder occurred in three patients, including
Down’s syndrome, VACTERL-association, and un-
classified dysmorphic features in one each. Clinical
symptoms at the time of presentation of the 33
patients who were not diagnosed prenatally are
shown in Table 1. Additional cardiac anomalies and
morbities occurred in 90% of all patients (Table 2).
Left ventricular ejection fraction was reduced in two
of five patients with a left ventricular noncompac-
tion. Of the 11 patients with Wolff–Parkinson–
White syndrome, two presented with tachycardia
postnatally, seven later in life, and the other two
remained asymptomatic.
Diagnosis was primarily made by transthoracic
echocardiography in all patients; cardiac magnetic
resonance imaging was additionally performed for
right ventricular evaluation in 11.
Invasive treatment was required in 33 of 42 patients
(79%; Fig 2).
At least one surgical intervention was necessary
in 21 patients (50%) at a median age of 9.1 years
(0.1–16.5).
Biventricular repair
Biventricular repair was achieved in 13 patients
(62%), and consisted of tricuspid valve reconstruction,
annuloplasty (DeVega), and closure of secundum atrial
septal defect if required. Figures 3 and 4 show a
12-year-old patient with moderate Ebstein’s anomaly
and severe, respectively, mild tricuspid regurgitation
before and after surgery. In two patients, a redo
tricuspid valve repair was necessary because of residual
severe regurgitation 2 weeks and 9 months, respec-
tively, after first repair. In two patients with atrial
reentry tachycardia, cryoablation was performed in the
right atrium during surgery. Pacemaker implantation
Figure 1.
Age distribution at the time of diagnosis of Ebstein’s anomaly in
children.
Table 1. Clinical presentation.
Symptoms Number of patients (%)
Heart murmur 14 (33)
Cyanosis 12 (29)
Arrhythmias 2 (5)
Congestive heart failure 2 (5)
Syndromal disorder 3 (7) Figure 2.
Summary of interventions. ASD5 atrial septal defect.
Table 2. Cardiac anomalies and morbidities.
Cardiac anomaly Number of patients (%)
Interatrial shunts 33 (79)
Secundum atrial septal defect 23
Persistent foramen ovale 10
PA/pulmonary stenosis 7 (17)
Anatomic PA 2
Functional PA 2
Valvular stenosis 3
Left ventricular noncompaction 5 (12)
Ventricular septal defect 3 (7)
Hypoplastic pulmonary artery branches 1 (2)
Coarctation of aorta 1 (2)
Wolff–Parkinson–White syndrome 11 (26)
PA5 Pulmonary atresia
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was necessary in one patient because of sick sinus
syndrome. Pre-operative radiofrequency ablation was
performed in four patients with a Wolff–Parkinson–
White syndrome.
One-and-a-half ventricle repair
Approximately 33%, that is, seven, children were
palliated with a cavopulmonary anastomosis result-
ing in a one-and-a-half ventricle repair. In these
patients, a modified Blalock–Taussig Shunt was first
performed in the neonatal period. The bidirectional
cavopulmonary anastomosis was then performed at a
median age of 7.4 years (0.4–12.8 years). Of these
patients, four additionally had an anatomical or
functional pulmonary atresia with insufficient
pulmonary blood flow. In one case, cavopulmonary
anastomosis was taken down and physiology returned
successfully into a biventricular repair after 2.8 years.
Figure 3.
Transthoracic echocardiography of a 12-year-old patient with moderate form of Ebstein anomaly and severe tricuspid regurgitation. Apical 4
chamber view. ARV5atrialised right ventricle; LV5 left ventricle; RA5 right atrium; RV5right ventricle; arrow points to apical
displacement of the septal tricuspid valve leaflet.
Figure 4.
Transthoracic echocardiography of the same patient as in Figure 3 after surgical repair. Apical 4 chamber view. LV5 left ventricle;
RA5 right atrium; RV5right ventricle; arrow points to reconstructed tricuspid valve.
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This patient had previously obtained tricuspid valve
replacement by using insertion of a Contegras
xenograft housed in a Goretexs tube in tricuspid
position at the age of 6 months. The xenograft
required repeated replacement at the age of 1.5 and
2.5 years because of inadequate size during somatic
growth. At the end of follow-up, this patient was
5 years old and presented in functional class II
receiving diuretics, betablocker, and aspirin medi-
cation. There was one patient who underwent
radiofrequency ablation before cavopulmonary ana-
stomosis and another in whom one right-sided
cryoablation was performed during surgery, because
of recurrent intraatrial tachycardias.
Single-ventricle palliation
There was one patient (5%) with Ebstein’s anomaly
and severe right ventricular hypoplasia who was
treated with a staged univentricular repair (Fontan),
consisting of Blalock–Taussig Shunt during the
neonatal period, a bidirectional cavopulmonary
anastomosis at the age of 2.1 years, and an extracardiac
conduit and obliteration of the right ventricle at the
age of 4.5 years.
Catheter interventions
A transcatheter device closure of a secundum atrial
septal defect using an Amplatzers (AGA Medical
Corporation, Golden Valley, Minnesota, United
States of America) Septal Occluder was performed
successfully in three patients (7%). None of these
patients had preceding additional surgery. Indication
for interventional closure was ventricular volume
overload without cyanosis in one child and mild
cyanosis (O2 saturation 90%) due to bidirectional
shunting across the atrial septum, as well as New York
Heart Association functional class II in the other two.
The median age at device closure was 13.9 years
(1.2–16.4 years). In all patients, oxygen saturation
improved to over 95% and no right ventricular failure
or increase in tricuspid regurgitation occurred during
follow-up.
Catheter ablation of the accessory pathway was
performed in 11 patients with Wolff–Parkinson–
White Syndrome, at a median age of 9.3 years
(6.1–14.5 years), and successfully completed with-
out any arrhythmia recurrence in 78% of the cases.
In two patients, ablation was not effective; in one of
these patients, a second catheter ablation was success-
ful, whereas in the other patient surgical cryoablation
was performed at time of surgical repair.
Follow-up
Median follow-up was 9.2 years (1 month to 29.4 years).
All patients after tricuspid valve reconstruction were
in functional classes I–II without any medication.
The regurgitation on echocardiography ranged from
mild to moderate. Patients with cavopulmonary
anastomosis usually were in functional class II, with
50% of them receiving diuretics.
In all, six patients died. Peri-operative mortality
was 4%, as one neonate died early post-operatively.
Approximately 7%, that is, three, patients died
postnatally because of congestive heart failure before
they could undergo surgical repair. Of the patients, two
were born prematurely at 31 and 36 gestational weeks,
respectively, and one presented with hydrops fetalis. In
both, the diagnosis Ebstein’s anomaly was known
prenatally. There were two patients who had a sudden
cardiac death; one child under betablocker medication
and without any previous intervention died at the age
of 3.4 years because of cardiovascular collapse caused by
intraatrial reentry tachycardia. The other patient, who
had been previously palliated with a modified Blalock–
Taussig Shunt, presented with a severe viral infection
and in dismal conditions at the age of 6 months.
The 10-year survival estimate was 85.3 plus or
minus 5.6% (Fig 5).
Discussion
This paper reports the clinical presentation and our
treatment algorithms, as well as outcome of children
diagnosed with Ebstein’s anomaly. Despite a severe
form of Ebstein’s anomaly in most of these children,
outcome in this series was quite good; however, this
required frequent interventions. Contrarily to adults,
these interventions rarely include tricuspid valve
replacement, but tricuspid valve repair, besides closure
of interatrial communications and arrhythmia surgery.
Figure 5.
Kaplan–Meier survival curve.
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Diagnosis and presentation of Ebstein’s anomaly
In patients with Ebstein’s anomaly, varying degrees of
right ventricular dysfunction and tricuspid regurgita-
tion, presence of an interatrial shunting, and/or right
ventricular outflow tract obstruction yield to a wide
spectrum of presentation. In addition, arrhythmias
may originate from reentry pathways and from right
atrial dilatation because of volume overload. The
clinical symptoms of the disease are mainly correlated
to the age of the patient. Thus, newborns may present
severely symptomatic with cyanosis and congestive
heart failure.10 In contrast, adult patients usually
present with exercise intolerance, tachyarrhythmias,
or signs of progressive congestive heart failure.17
The very young age at diagnosis observed in our
cohort reflects the fact that clinical conditions are
worse in younger patients.9,11 Prenatal diagnosis was
made in 21% of our patient group reflecting severe
Ebstein’s anomaly, as 56% of them died during the
first 3.4 years of life. Survival of young children with
severe Ebstein’s anomaly is mainly warranted by early
intervention, as it was the case in 79% of our patients.
Diagnostic evaluation
Echocardiography is the first-line modality for
assessing Ebstein’s anomaly. As children present a
good imaging window, usually transthoracic echo-
cardiography enables accurate evaluation of the
tricuspid valve and the size and function of both
ventricles. Echocardiographic assessment should
include evaluation of abnormal trabeculations in
the left ventricle, as left myocardial noncompaction
in Ebstein’s anomaly has been described,3 and impaired
left ventricular function may worsen prognosis. In our
cohort, left ventricular noncompaction was diagnosed
in five patients by echocardiography. None of these
patients showed signs of left heart failure.
Nowadays, cardiac magnetic resonance is of
additional value for exact quantitative right ven-
tricular assessment (Fig 6), and demonstration of
the displacement of the tricuspid valve leaflets in all
three dimensions (Supplementary Movie S1), which
can be useful when planning surgical repair during
follow-up, if cardiac failure occurs. Cardiac mag-
netic resonance is the ideal modality for serial
quantification of right ventricular function.18
Surgical interventions in young children with
Ebstein’s anomaly
Management of neonates with Ebstein’s anomaly is
challenging and needs to be individualised for each
particular patient. Biventricular repair is usually
preferable if the right ventricular size and function
are adequate. Surgical repair with tricuspid valve
reconstruction can be performed in young children
with low mortality and good long-term durability
of the valve, provided that tricuspid valve compe-
tence is achieved.19,20 Whenever feasible, in
children tricuspid valve reconstruction is preferable
to valve replacement. In addition to well-known
complications such as thromboembolism, endocar-
ditis, and valvular degeneration, in neonates and
small children valve prosthesis may be too large at
the time of insertion, with the risk of disruption
of the geometry of the adjacent structures. Later
during somatic growth the valve may result too
small. In our series, biventricular repair with
tricuspid valve reconstruction was achieved in
62% of the patients undergoing surgery. Never-
theless, a redo rate of 15% for tricuspid valve
reconstruction reflects the challenges of this valve
reconstruction during infancy.
In neonates requiring initial palliation with a
systemic-to-pulmonary shunt, a one-and-a-half
ventricle repair with a cavopulmonary anastomosis
should be considered after 2–3 months if their
functional capacity of the right ventricle remains
marginal or insufficient. A well-functioning one-
and-a-half ventricle repair with an unloaded right
ventricle may be preferable to a compromised
biventricular repair.21,22 The prevalence of 38% of
children who underwent one-and-a-half ventricle
repair observed in our cohort is similar to the one
reported by the European Congenital Heart Sur-
geons Association.22 However, the same authors
report significantly higher mortality in young
infants and higher rate of tricuspid valve replace-
ment even in older patients, than we found in our
Figure 6.
Steady-state free precession cardiovascular magnetic resonance
image in an axial plane showing severe displacement of the septal
leaflet (black arrow) and a coaptation deficit of the tricuspid valve
(white arrow). ARV5atrialised right ventricle; RA5 right
atrium; RV5right ventricle.
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study. Thus, considering that symptomatic neonates
with Ebstein’s anomaly tend to have unfavourable
anatomic and pathophysiologic conditions with
potentially a worse prognosis, our data may suggest
that an accurate planning and an individual-
ised treatment strategy enable successful surgical
approach towards biventricular repair and preservation
of the tricuspid valve.19
Treatment strategies for tachyarrhythmias
Radiofrequency ablation is safe and effective for
treatment of various types of tachycardias occurring
in Ebstein’s anomaly.23 Nevertheless, in patients
with Ebstein’s anomaly, catheter ablation presents
lower success rate with some arrhythmia recurrence
in comparison with procedures performed in
structurally normal hearts.24 In contrast, surgical
cryoablation for accessory pathway-mediated tachy-
cardia provides excellent results with freedom from
arrhythmia recurrence.25,26 In our patients, the
success rate of radiofrequency ablation was 78%.
Owing to the fact that arrhythmias are one of the
leading symptoms in older children and adults with
Ebstein’s anomaly, an accurate electrophysiological
investigation is indicated already during childhood
and radiofrequency ablation of accessory pathways
should be performed when appropriate. In case of
arrhythmias recurrence, surgical cryoablation can be
planned at the time of surgical repair.
Transcatheter device closure of interatrial shunts
Transcatheter device closure of a secundum atrial
septal defect can represent the only required interven-
tion in selected patients, without significant tricuspid
valve regurgitation and with good right ventricular
function. Atiq et al14 report about six children with
Ebstein’s anomaly and without prior procedures, who
received successful device closure of a secundum atrial
septal defect. Similarly, in our three cases transcatheter
device closure led to a normalisation of oxygen
saturation and improvement of clinical symptoms.
Thus, transcatheter device closure of a secundum atrial
septal defect in patients with Ebstein’s anomaly, who
do not require tricuspid valve repair, seems to be a safe
and efficient way of improving oxygen saturation
under rest and exercise. Moreover, it may help in
preventing paradoxical thromboembolisms.15 Never-
theless, when considering transcatheter device closure,
the degree of tricuspid valve regurgitation needs to be
previously carefully assessed, as interatrial shunt
closure alone may worsen right ventricular function.27
Limitations
This is a retrospective descriptive study. Even
though not exceedingly small for such a rare disease
like Ebstein’s anomaly, the size of our patient group,
and the few patients with adverse outcome did not
allow a statistical analysis for risk factors for poor
outcome. However, our findings reflect the observa-
tions reported by others, that neonates with cyanosis
and/or congestive heart failure are the group at risk
for mortality. In fact, five of the six deaths in our
patient group consisted of neonates with a severe
form of Ebstein’s anomaly.
Conclusion
Ebstein’s anomaly is a complex congenital structural
heart defect with a broad anatomic and clinical
spectrum. In particular, the management of newborn
patients, usually affected by the most severe form of
the disease, is challenging. An individualised treat-
ment strategy considering the clinical symptoms of the
patient, the anatomic and haemodynamic conditions
and the associated abnormalities, and the choice of the
most appropriate interventions, as surgery, catheter-
guided interventions, radiofrequency ablations, may
provide excellent results and good outcome.
Supplementary materials
For supplementary materials referred to in this
article, please visit http://dx.doi.org/doi:10.1017/
S1047951112000224
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